💉 AstraZeneca, Merck’s Lynparza gets FDA thumbs up; WHO’s drug dependence resource repository; Climate financing for gelato

Extreme heat sweeps across Asia; Learning from primate genomes; What’s hindering the HIV fight?

Hello and welcome to The Kable for the last time this week. 2022, it turns out, was the most violent year against health workers and facilities in conflicts in the past decade. More than half of the 1,989 attacks and threats documented were in only Ukraine and Myanmar.

The US FDA has given a greenlight to AstraZeneca and Merck’s Lynparza for limited use …